Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126816252 | 12681625 | 2 | F | 201111 | 20160829 | 20160824 | 20160901 | EXP | US-009507513-1608USA012083 | MERCK | 0.00 | M | Y | 85.71000 | KG | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126816252 | 12681625 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 50MG, QD | U | 21995 | 50 | MG | FILM-COATED TABLET | QD | |||||
| 126816252 | 12681625 | 2 | SS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100MG, QD | U | 21995 | 100 | MG | FILM-COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126816252 | 12681625 | 1 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126816252 | 12681625 | DS |
| 126816252 | 12681625 | HO |
| 126816252 | 12681625 | DE |
| 126816252 | 12681625 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126816252 | 12681625 | Adverse event | |
| 126816252 | 12681625 | Anal incontinence | |
| 126816252 | 12681625 | Arthralgia | |
| 126816252 | 12681625 | Benign prostatic hyperplasia | |
| 126816252 | 12681625 | Cholelithiasis | |
| 126816252 | 12681625 | Depressed mood | |
| 126816252 | 12681625 | Emphysema | |
| 126816252 | 12681625 | Haemorrhoids | |
| 126816252 | 12681625 | Hypertension | |
| 126816252 | 12681625 | Malaise | |
| 126816252 | 12681625 | Metastases to bone | |
| 126816252 | 12681625 | Metastases to liver | |
| 126816252 | 12681625 | Muscular weakness | |
| 126816252 | 12681625 | Nervousness | |
| 126816252 | 12681625 | Oedema peripheral | |
| 126816252 | 12681625 | Osteoarthritis | |
| 126816252 | 12681625 | Pancreatic carcinoma metastatic | |
| 126816252 | 12681625 | Pancreatitis chronic | |
| 126816252 | 12681625 | Pelvic pain | |
| 126816252 | 12681625 | Pollakiuria | |
| 126816252 | 12681625 | Polyp | |
| 126816252 | 12681625 | Purpura senile | |
| 126816252 | 12681625 | Rectal tenesmus | |
| 126816252 | 12681625 | Sleep apnoea syndrome | |
| 126816252 | 12681625 | Steroid therapy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126816252 | 12681625 | 1 | 20111118 | 20121013 | 0 | |
| 126816252 | 12681625 | 2 | 20111118 | 20121013 | 0 |